摘要
世界正在老化,我们必须面对这带来的挑战。世界人口老龄化加剧的原因之一是预期寿命的增加,而且,由于我们的寿命更长,因此,良好的生活和预防与年龄有关的疾病至关重要。通过这种方式,提高对衰老过程及其机制的认识至关重要。理想情况下,有一组健康衰老的生物标志物,可以估计一个人的生物学年龄,这将是非常有意义的。对衰老有很大贡献的变化之一是蛋白质稳态的丧失,也被称为蛋白质平衡。为了确保细胞的正常功能和维持细胞的蛋白质平衡,生物体开发了控制蛋白质合成、折叠和降解的系统。蛋白质平衡的丧失或功能障碍是许多经过深入研究的人类神经系统疾病的根源,例如阿尔茨海默病,最近,它与衰老过程有牵连,一些报告显示长寿的动物已经改善了蛋白质平衡。越来越多的证据表明,参与蛋白质平衡和长寿的几个参与者的数量和/或活动的变化之间存在着密切的联系。在这篇综述中,我们概述了衰老的主要特征,重点是蛋白质平衡。我们介绍了衰老过程中蛋白质平衡成分的变化如何影响模型生物体的寿命。我们还简要回顾了衰老生物标记物的现状,并讨论了蛋白质平衡网络元件作为健康衰老标志的潜力。
关键词: 老化,蛋白质平衡,蛋白酶体,伴侣,蛋白质聚集物,衰老的生物标志。
Current Molecular Medicine
Title:Aging and Proteins: What Does Proteostasis Have to Do with Age?
Volume: 18 Issue: 3
关键词: 老化,蛋白质平衡,蛋白酶体,伴侣,蛋白质聚集物,衰老的生物标志。
摘要: The world is aging and we must face the challenges that this brings. One of the reasons for the increasing aging of the world’s population is the increase in life expectancy and, since we live longer, it is of paramount importance to live well and to prevent age-associated diseases. In this way, it is crucial to improve knowledge of the aging process and of the mechanisms that contribute to it. Ideally it would be of great interest to have a panel of biomarkers of healthy aging that would allow an estimate of the biological age of an individual. One of the changes that greatly contribute to aging is the loss of protein homeostasis, also called proteostasis. To ensure the proper function of cells and to maintain cellular proteostasis, organisms have developed systems to control protein synthesis, folding and degradation. Loss or dysfunction of proteostasis is at the root of many well-studied human neurological diseases, such as Alzheimer’s disease and, more recently, it has been implicated in the aging process with some reports showing long-lived animals to have improved proteostasis. Growing evidence suggests a strong link between modifications in the quantity and/or activity of several players involved in proteostasis and longevity. In this review, we give an overview of the main characteristics of aging with focus on proteostasis. We present how changes in components of proteostasis, during aging, impact the lifespan of model organisms. We also briefly review the current state of aging biomarkers and discuss the potential of proteostasis network components as markers of healthy aging.
Export Options
About this article
Cite this article as:
Aging and Proteins: What Does Proteostasis Have to Do with Age?, Current Molecular Medicine 2018; 18 (3) . https://dx.doi.org/10.2174/1566524018666180907162955
DOI https://dx.doi.org/10.2174/1566524018666180907162955 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Reversal of Bone Cancer Pain by HSV-1-Mediated Silencing of CNTF in an Afferent Area of the Spinal Cord Associated with AKT-ERK Signal Inhibition
Current Gene Therapy Natural Sirtuin Modulators in Drug Discovery: A Review (2010 -2020)
Current Medicinal Chemistry Rapid and Solventless Analysis of Polychlorinated Biphenyls in Packaged Milk Using Gas Chromatography
Current Chromatography Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review
Drug Delivery Letters Strategies for Skeletal Muscle Targeting in Drug Discovery
Current Pharmaceutical Design Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry Role of Methylene Blue in Trauma Neuroprotection and Neuropsychiatric Diseases
CNS & Neurological Disorders - Drug Targets Role of Metal Ions in the Aβ Oligomerization in Alzheimers Disease and in Other Neurological Disorders
Current Alzheimer Research Exercise-Induced MicroRNA Regulation in the Mice Nervous System is Maintained After Activity Cessation
MicroRNA Pathologically-Activated Therapeutics for Neuroprotection: Mechanism of NMDA Receptor Block by Memantine and S-Nitrosylation
Current Drug Targets Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity
Current Medicinal Chemistry Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume I)
CNS & Neurological Disorders - Drug Targets Cell to Cell Spreading of Misfolded Proteins as a Therapeutic Target in Motor Neuron Disease
Current Medicinal Chemistry CHIP Knockdown Reduced Heat Shock Response and Protein Quality Control Capacity in Lens Epithelial Cells
Current Molecular Medicine Cysteine Network (CYSTEINET) Dysregulation in Parkinson’s Disease: Role of N-acetylcysteine
Current Drug Metabolism Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism
Current Drug Metabolism Structural Activity Relationship and Importance of Benzothiazole Derivatives in Medicinal Chemistry: A Comprehensive Review
Mini-Reviews in Organic Chemistry Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review
Current Clinical Pharmacology The Heat Shock Connection of Metabolic Stress and Dietary Restriction
Current Pharmaceutical Biotechnology